Drug intelligence / Profile preview

1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole

Development stage
Unknown
Modality
Small Molecules
01

Overview

A synthetic small molecule belonging to the phenylpyrazole class, 1‑Phenylsulfonamide‑3‑Trifluoromethyl‑5‑Parabromophenylpyrazole (also known as SC‑558), is a potent and selective inhibitor of prostaglandin G/H synthase 2 (commonly known as cyclooxygenase‑2 or COX‑2). It is not approved for clinical use but has been widely used in research to study COX‑2 inhibition. The compound exhibits high selectivity for COX‑2 over COX‑1, with an IC50 value of approximately 9.3 nM for COX‑2 inhibition[2][3]. Its primary application is in experimental pharmacology and biochemistry as a tool compound to investigate inflammatory pathways mediated by prostaglandins.

Other names
4-(5-(4-bromophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzene-1-sulfonamide4-[5-(4-bromophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide4-[5-(4-bromophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamidebenzenesulfonamide, 4-[5-(4-bromophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl]-
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call